[Form 3] Minerva Neurosciences, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Minerva Neurosciences, Inc. (NERV) reported a new insider filing on Form 3 for an individual serving as a director of the company. The event date for this initial ownership statement is 11/14/2025. According to the filing, the reporting person currently has no securities beneficially owned, meaning they do not hold Minerva Neurosciences stock or related derivative securities in their name or through indirect arrangements as of that date.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kaul Inderjit

(Last) (First) (Middle)

C/O MINERVA NEUROSCIENCES, INC.

1500 DISTRICT AVENUE

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/14/2025

3. Issuer Name and Ticker or Trading Symbol
Minerva Neurosciences, Inc. [ NERV ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Frederick Ahlholm, Attorney-in-Fact	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the NERV Form 3 filed on 11/14/2025 show?

The Form 3 for Minerva Neurosciences, Inc. (NERV) dated 11/14/2025 shows that the reporting person, a director of the company, reported no securities beneficially owned at that time.

Who is the reporting person in the NERV Form 3 and what is their role?

The reporting person in this Form 3 is identified as a director of Minerva Neurosciences, Inc., indicating they serve on the company’s board but, per the filing, currently report no ownership of company securities.

Does the NERV Form 3 report any shares or options owned by the director?

No. The filing explicitly states in the Explanation of Responses section that no securities are beneficially owned, and both the non-derivative and derivative securities tables show no reported holdings.

What is the significance of a Form 3 with no securities beneficially owned for NERV?

A Form 3 with no securities beneficially owned indicates that, as of the reported date, the director does not hold Minerva Neurosciences stock or related derivative securities, even though they are now an insider subject to reporting obligations.

Is the NERV Form 3 filed by one or multiple reporting persons?

The form is indicated as Form filed by One Reporting Person, meaning only a single director is covered in this ownership report.

Does the NERV Form 3 include any indirect ownership of securities?

No. The filing’s explanation states no securities are beneficially owned, and there is no disclosure of indirect ownership in the tables.